Shanghai Haoyuan Chemexpress Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Haoyuan Chemexpress has a total shareholder equity of CN¥2.7B and total debt of CN¥988.0M, which brings its debt-to-equity ratio to 36.3%. Its total assets and total liabilities are CN¥4.7B and CN¥2.0B respectively. Shanghai Haoyuan Chemexpress's EBIT is CN¥188.0M making its interest coverage ratio 5.4. It has cash and short-term investments of CN¥497.4M.
Key information
36.3%
Debt to equity ratio
CN¥988.05m
Debt
| Interest coverage ratio | 5.4x |
| Cash | CN¥497.45m |
| Equity | CN¥2.72b |
| Total liabilities | CN¥1.96b |
| Total assets | CN¥4.68b |
Recent financial health updates
Does Shanghai Haoyuan Chemexpress (SHSE:688131) Have A Healthy Balance Sheet?
Oct 16
Shanghai Haoyuan Chemexpress (SHSE:688131) Has A Somewhat Strained Balance Sheet
Jun 13Recent updates
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Shares Climb 36% But Its Business Is Yet to Catch Up
Nov 06Does Shanghai Haoyuan Chemexpress (SHSE:688131) Have A Healthy Balance Sheet?
Oct 16Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) 25% Jump Shows Its Popularity With Investors
Sep 19Investors Appear Satisfied With Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Prospects
Jul 13Shanghai Haoyuan Chemexpress (SHSE:688131) Has A Somewhat Strained Balance Sheet
Jun 13Earnings Troubles May Signal Larger Issues for Shanghai Haoyuan Chemexpress (SHSE:688131) Shareholders
May 06After Leaping 27% Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) Shares Are Not Flying Under The Radar
Mar 20Financial Position Analysis
Short Term Liabilities: 688131's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 688131's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥751.8M).
Debt to Equity History and Analysis
Debt Level: 688131's net debt to equity ratio (18%) is considered satisfactory.
Reducing Debt: 688131's debt to equity ratio has increased from 8% to 36.3% over the past 5 years.
Debt Coverage: 688131's debt is well covered by operating cash flow (29.3%).
Interest Coverage: 688131's interest payments on its debt are well covered by EBIT (5.4x coverage).